150 related articles for article (PubMed ID: 17931111)
1. Leukotriene B4-mediated release of antimicrobial peptides against cytomegalovirus is BLT1 dependent.
Gaudreault E; Gosselin J
Viral Immunol; 2007 Sep; 20(3):407-20. PubMed ID: 17931111
[TBL] [Abstract][Full Text] [Related]
2. Leukotriene B4 induces release of antimicrobial peptides in lungs of virally infected mice.
Gaudreault E; Gosselin J
J Immunol; 2008 May; 180(9):6211-21. PubMed ID: 18424743
[TBL] [Abstract][Full Text] [Related]
3. Modulation of leukotriene B4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival.
Stankova J; Turcotte S; Harris J; Rola-Pleszczynski M
J Immunol; 2002 Apr; 168(7):3570-6. PubMed ID: 11907121
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.
Wan M; Godson C; Guiry PJ; Agerberth B; Haeggström JZ
FASEB J; 2011 May; 25(5):1697-705. PubMed ID: 21307335
[TBL] [Abstract][Full Text] [Related]
5. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation.
Arita M; Ohira T; Sun YP; Elangovan S; Chiang N; Serhan CN
J Immunol; 2007 Mar; 178(6):3912-7. PubMed ID: 17339491
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene B(4) receptors BLT1 and BLT2 are involved in interleukin-8 production in human neutrophils induced by Trichomonas vaginalis-derived secretory products.
Nam YH; Min A; Kim SH; Lee YA; Kim KA; Song KJ; Shin MH
Inflamm Res; 2012 Feb; 61(2):97-102. PubMed ID: 22215047
[TBL] [Abstract][Full Text] [Related]
7. Release of anti-HIV mediators after administration of leukotriene B4 to humans.
Flamand L; Borgeat P; Lalonde R; Gosselin J
J Infect Dis; 2004 Jun; 189(11):2001-9. PubMed ID: 15143466
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene B4 augments and restores Fc gammaRs-dependent phagocytosis in macrophages.
Okamoto F; Saeki K; Sumimoto H; Yamasaki S; Yokomizo T
J Biol Chem; 2010 Dec; 285(52):41113-21. PubMed ID: 20959460
[TBL] [Abstract][Full Text] [Related]
9. Requirement of phosphatidylinositol 3-kinase activation and calcium influx for leukotriene B4-induced enzyme release.
Ito N; Yokomizo T; Sasaki T; Kurosu H; Penninger J; Kanaho Y; Katada T; Hanaoka K; Shimizu T
J Biol Chem; 2002 Nov; 277(47):44898-904. PubMed ID: 12244116
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4 triggers release of the cathelicidin LL-37 from human neutrophils: novel lipid-peptide interactions in innate immune responses.
Wan M; Sabirsh A; Wetterholm A; Agerberth B; Haeggström JZ
FASEB J; 2007 Sep; 21(11):2897-905. PubMed ID: 17446260
[TBL] [Abstract][Full Text] [Related]
11. The role of leukotriene B(4) in allergic diseases.
Ohnishi H; Miyahara N; Gelfand EW
Allergol Int; 2008 Dec; 57(4):291-8. PubMed ID: 18797182
[TBL] [Abstract][Full Text] [Related]
12. The leukotriene B
Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene B₄-leukotriene B₄ receptor axis promotes oxazolone-induced contact dermatitis by directing skin homing of neutrophils and CD8⁺ T cells.
Lv J; Zou L; Zhao L; Yang W; Xiong Y; Li B; He R
Immunology; 2015 Sep; 146(1):50-8. PubMed ID: 25959240
[TBL] [Abstract][Full Text] [Related]
14. BLT1 and BLT2: the leukotriene B(4) receptors.
Tager AM; Luster AD
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):123-34. PubMed ID: 12895595
[TBL] [Abstract][Full Text] [Related]
15. Involvement of BLT1 endocytosis and Yes kinase activation in leukotriene B4-induced neutrophil degranulation.
Gaudreault E; Thompson C; Stankova J; Rola-Pleszczynski M
J Immunol; 2005 Mar; 174(6):3617-25. PubMed ID: 15749899
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene B4 mediates neutrophil migration induced by heme.
Monteiro AP; Pinheiro CS; Luna-Gomes T; Alves LR; Maya-Monteiro CM; Porto BN; Barja-Fidalgo C; Benjamim CF; Peters-Golden M; Bandeira-Melo C; Bozza MT; Canetti C
J Immunol; 2011 Jun; 186(11):6562-7. PubMed ID: 21536805
[TBL] [Abstract][Full Text] [Related]
17. 20-Hydroxy- and 20-carboxy-leukotriene (LT) B
Archambault AS; Poirier S; Lefebvre JS; Robichaud PP; Larose MC; Turcotte C; Martin C; Provost V; Boudreau LH; McDonald PP; Laviolette M; Surette ME; Flamand N
J Leukoc Biol; 2019 Jun; 105(6):1131-1142. PubMed ID: 30676680
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene B4-induced changes in vascular permeability are mediated by neutrophil release of heparin-binding protein (HBP/CAP37/azurocidin).
Di Gennaro A; Kenne E; Wan M; Soehnlein O; Lindbom L; Haeggström JZ
FASEB J; 2009 Jun; 23(6):1750-7. PubMed ID: 19151333
[TBL] [Abstract][Full Text] [Related]
19. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders.
Yokomizo T; Kato K; Terawaki K; Izumi T; Shimizu T
J Exp Med; 2000 Aug; 192(3):421-32. PubMed ID: 10934230
[TBL] [Abstract][Full Text] [Related]
20. Amplification of extracellular nucleotide-induced leukocyte(s) degranulation by contingent autocrine and paracrine mode of leukotriene-mediated chemokine receptor activation.
Kannan S
Med Hypotheses; 2002 Sep; 59(3):261-5. PubMed ID: 12208150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
